Staff List

The following is the staff list for the EGRP. To jump to the list for a specific branch, click on the branch acronym in the bulleted list below:

OR, You may click on the table headers to sort the staff by the individual columns.

Branch Name/Title Contact Info Interest Areas
OAD Office of the Associate Director    
OAD Muin J. Khoury, M.D., Ph.D.
Associate Director (Acting) and Knowledge Management Unit Lead (Acting)
301-496-9600
khourym@mail.nih.gov
Epidemiologic methods in research, policy, and practice; Human genome epidemiology; Public health genomics; Multidisciplinary translation research; Cancer Epidemiology and Genomics
OAD Anderson, Linda, M.P.A.
Contractor, Communications Consultant
301-594-7348
andersonli@mail.nih.gov
 
OAD Babkirk, Audrey, M.P.H.
Cancer Research Training Award Fellow
301-435-4736
babkirkaj@mail.nih.gov
New media for health communication, reproductive health, behavioral economics, social entrepreneurship, HIV/AIDS, and global health
OAD Beard, Dacia, M.P.H., C.H.E.S.
Cancer Research Training Award Fellow
301-435-4907
bearddd@mail.nih.gov
Health communication, program evaluation, implementation and dissemination sciences, health disparities, community-based participatory research, project management
OAD Burgio, Michael R., Ph.D.
Contractor, Consortia Coordinator, Cancer Family Registry
301-670-4990
burgiom@mail.nih.gov
 
OAD Carter, Daniel
Contractor, Management Analyst
301-402-7199
carterdr@mail.nih.gov
 
OAD Chang, Christine, M.P.H.
Cancer Research Training Award Fellow
301-594-2243
christine.chang2@nih.gov
Cancer epidemiology, modifiable risk factors and health-related behaviors, communicating health information to the lay public, use of GIS in public health
OAD DeRycke, Eric, M.P.H.
Cancer Research Training Award Fellow
301-594-9178
eric.derycke@nih.gov
Genomic epidemiology of cancer
OAD Harvey, Chinonye (Nonye), M.P.H.
Public Health Advisor
301-594-3667
harveyn@mail.nih.gov
Global health, health disparities research, role of lifestyle and the environment and early life exposures in cancer and cancer-related outcomes
OAD Kaefer, Christine M., M.B.A., R.D.
Communications Coordinator
301-435-4906
kaeferc@mail.nih.gov
Translating scientific findings for diverse audiences, communicating complex health risk information
OAD Kaminski, Brett, M.P.H.
Cancer Research Training Award Fellow
301-435-6615
brett.kaminski@nih.gov
 
OAD Lam, Tram K., Ph.D., M.P.H.
Program Director, Knowledge Integration Team
301-435-2384
lamt@nih.gov
Using the tools of Knowledge Integration to canvas the interdisciplinary field of cancer epidemiology and advance research by synthesizing prior knowledge, incorporating new information, identifying gaps, and translating findings. Investigating how environmental factors influence or interact with genomic factors, and how these affect cancers and cancer outcomes.
OAD Rogers, Scott D., M.P.H.
Public Health Advisor
301-594-7346
rogerssc@mail.nih.gov
Genetic susceptibility to cancer
OAD Schully, Sheri D., Ph.D.
Knowledge Integration Team Lead
301-435-4911
schullys@mail.nih.gov
Using the tools of Knowledge Integration to uncover what is known or unknown about cancer epidemiology, translation of genome-based knowledge and technologies to improve population health and the use of biospecimens in research
OAD Seminara, Daniela, Ph.D., M.P.H.
Senior Scientist and Scientific Consortia Coordinator
301-496-9600
seminard@mail.nih.gov
Genomic epidemiology of cancer, including gene-gene and gene-environment interactions; Application of genomic epidemiology to public health, disease prevention, and therapy; Cross-disciplinary knowledge synthesis in cancer and other complex diseases; Familial cancer registries; Collaborative research through interdisciplinary cancer consortia, including data sharing policies
OAD Tabron, Felicia
Program Specialist
301-435-4736
tabronfa@mail.nih.gov
 
OAD Thompson, Marta
Program Specialist
301-435-4915
thompsonma@mail.nih.gov
 
CTEB Clinical and Translational Epidemiology Branch    
CTEB Freedman, Andrew N., Ph.D.
Branch Chief
301-435-6819
freedmaa@mail.nih.gov
Developing, applying, and evaluating prediction models for cancer risk and prognosis; developing benefit/risk indices for pharmaceuticals used to prevent and treat cancer; and identifying clinical, epidemiologic, and pharmacogenomic factors related to cancer treatment outcomes
CTEB Cook, Allison
Extramural Support Specialist
301-594-1744
cookal@mail.nih.gov
Cancer and the Environment, Global Health, Risk Communication about Environmental Public Health, Long-term Effects of Exposure to Radiation and Toxins, Food Security, Urban Public Health Systems
CTEB Filipski, Kelly K., Ph.D., M.P.H.
Program Director
301-435-4913
filipskikk@mail.nih.gov
Pharmacogenomic factors related to cancer treatment outcomes and toxicity
CTEB Ishibe Simonds, Naoko, Sc.D.
Program Director
301-594-1845
ishiben@mail.nih.gov
Genetic and translational epidemiology, comparative effectiveness research, pharmacogenetics
CTEB Shelburne, Nonniekaye F., C.R.N.P., M.S., A.O.C.N.
Program Director
301-594-6809
nshelburne@mail.nih.gov
Benefit-risk prediction models for clinical oncology practice related to cancer treatment outcomes and toxicity
CTEB Watters Elena, Joanne, Ph.D., M.P.H.
Program Director
301-451-9875
wattersj@mail.nih.gov
Dietary and lifestyle risk factors related to cancer progression, recurrence, and survival outcomes
CTEB Zhou, Yingjun (Grace), M.S.
Cancer Research Training Award Fellow
301-594-2256
grace.zhou@nih.gov
Pharmacoepidemiology and drug safety, prediction models for cancer risks and treatment outcomes
HSFB Host Susceptibility Factors Branch    
HSFB Gillanders, Elizabeth M., Ph.D.
Branch Chief
301-594-5868
lgilland@mail.nih.gov
Genetic epidemiology of cancer
HSFB Buccini, Laura D., Dr.P.H., M.P.H.
Bioethicist, Contractor
301-435-2384
buccinild@mail.nih.gov
Public health and research ethics, specifically the intersection between genetic/genomic research with issues surrounding informed consent, informed decision making, access, and sharing of data
HSFB Carrick, Danielle Mercatante, Ph.D., M.H.S.
Program Director
301-594-2389
carrick@mail.nih.gov
Immunology, infectious diseases, and autoimmune diseases associated with cancer risk; pharmacoepidemiology and pharmacogenomics in relation to cancer risk; biospecimen research; translational medicine
HSFB Green, Tiffany, M.H.S., M.P.H.
Contractor, Program Analyst
301-594-7348
greentif@mail.nih.gov
Ethical and social issues surrounding advances in the genetic epidemiology of cancer and infectious diseases
HSFB Hutter, Carolyn M., Ph.D.
Program Director
301-435-4910
huttercm@mail.nih.gov
Genetic epidemiology, statistical methods, and post-GWAS research
HSFB Lepage, Pascale, Ph.D.
Contractor, Public Health Advisor
301-594-3652
lepagep@mail.nih.gov
Molecular biology of lung cancer
HSFB Martin, Damali N., Ph.D., M.P.H.
Program Director
301-451-1956
martinda@mail.nih.gov
Health disparities research, specifically for breast and prostate cancer and whether tumor biology contributes to differences in survival between African-American and Caucasian breast and prostate cancer patients
HSFB Mechanic, Leah E., Ph.D., M.P.H.
Program Director
301-496-8105
mechanil@mail.nih.gov
Gene-gene and gene-environment interactions, biospecimen science, molecular epidemiology of lung cancer, hematological malignancies, and endometrial cancer
HSFB Mette, Eliza
Cancer Research Training Award Fellow
301-594-2244
metteer@mail.nih.gov
Global and domestic health disparities research and the role of social and behavioral factors associated with cancer risk
HSFB Nelson, Stefanie A., Ph.D.
Program Director
301-435-6613
nelsons@mail.nih.gov
Genetic differences affecting cancer risk and response to treatment, understanding the function of cancer risk variants, and interactions between the germline and somatic cancer genomes
HSFB Tingle, Sharna, M.P.H.
Cancer Research Training Award Fellow
301-594-7348
tinglesr@mail.nih.gov
Health policy, bioethics, and public health genetics
HSFB Zanetti, Krista A., Ph.D., M.P.H., R.D.
Program Director
301-496-7250
zanettik@mail.nih.gov
Molecular epidemiology of lung and colon cancer, genome-wide association studies, use of emerging technologies in epidemiology studies, biological determinants of health disparities associated with cancer
MTB Methods and Technologies Branch    
MTB Verma, Mukesh, Ph.D.
Branch Chief
301-594-7344
vermam@mail.nih.gov
Biomarkers, Epigenetics, Epidemiology Technologies, Proteomics, MicroRNA, Methylation, Mitochondria, Nanotechnology, Risk Assessment, Susceptibility Factors, Systems Genetics, Metabolomics
MTB Cook, Sherri
Program Support Assistant
301-594-9342
cooksh@od.nih.gov
 
MTB Divi, Rao L., Ph.D.
Program Director
301-443-5539
divir@mail.nih.gov
Molecular Mechanisms of Cancer, Methods for Cancer Epidemiology, DNA Damage, Genomic Rearrangements, Chromosomal Translocations, Retrotransposons, Preclinical Markers, MicroRNA, Carcinogenesis, Transcriptomics, Functional Genomics, Molecular markers, Methods for Risk Assessment, Toxicity and Carcinogenicity, High-Throughput Screening
MTB Overton, Adrienne, M.P.A.
Program Analyst
301-594-3402
overtona@mail.nih.gov
 
MTB Starks, Vaurice L.
Program Director
301-402-9375
starksv@mail.nih.gov
Infectious disease epidemiology, focusing on HIV and HPV
MRFB Modifiable Risk Factors Branch    
MRFB Reid, Britt C., D.D.S., Ph.D.
Branch Chief
301-435-4914
reidbr@mail.nih.gov
Climate change, indoor air-pollution, comorbid conditions on health outcomes
MRFB Dold, Georgia
Extramural Support Specialist
301-435-2884
georgiadold@mail.nih.gov
 
MRFB Ellison, Gary L., Ph.D., M.P.H.
Program Director
301-402-1853
ellisong@mail.nih.gov
Role of lifestyle and environmental factors in cancer incidence and progression, psychosocial factors and cancer incidence and progression, cancer disparities, early environmental exposures
MRFB Mahabir, Somdat, Ph.D., M.P.H.
Program Director
301-496-0270
mahabir@mail.nih.gov
Mechanisms of obesity/adiposity characteristics, energy balance, diet, alcohol, and other modifiable environmental exposures in cancer etiology, prevention, treatment, and survival; Early life events/exposures and cancer later in life; Birth cohorts; Multi-ethnic cohorts; Childhood cancers
MRFB Su, L. Joseph, Ph.D., M.P.H.
Program Director
301-443-8066
sulj@mail.nih.gov
Dietary intake assessment, biomarkers associated with cancer etiology and prognosis, carcinogenic chemicals in foods, and molecular mechanisms that underlie cancer risk, such as epigenetic changes

Last Updated: 31 Aug 2011

Division of Cancer Control and Population Sciences National Cancer Institute Department of Health and Human Services National Institutes of Health USA.gov